Detalhe da pesquisa
1.
A replicon RNA vaccine can induce durable protective immunity from SARS-CoV-2 in nonhuman primates after neutralizing antibodies have waned.
PLoS Pathog
; 19(4): e1011298, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37075079
2.
Detailed analysis of antibody responses to SARS-CoV-2 vaccination and infection in macaques.
PLoS Pathog
; 18(4): e1010155, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35404959
3.
Accelerated DNA vaccine regimen provides protection against Crimean-Congo hemorrhagic fever virus challenge in a macaque model.
Mol Ther
; 31(2): 387-397, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36184852
4.
Chikungunya Virus Evades Antiviral CD8+ T Cell Responses To Establish Persistent Infection in Joint-Associated Tissues.
J Virol
; 94(9)2020 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32102875
5.
Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human Convalescence.
J Virol
; 93(18)2019 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292241
6.
Mutations in the E2 Glycoprotein and the 3' Untranslated Region Enhance Chikungunya Virus Virulence in Mice.
J Virol
; 91(20)2017 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28747508
7.
Animal Models of Chikungunya Virus Infection and Disease.
J Infect Dis
; 214(suppl 5): S482-S487, 2016 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27920178
8.
Attenuating mutations in nsP1 reveal tissue-specific mechanisms for control of Ross River virus infection.
J Virol
; 88(7): 3719-32, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24429363
9.
Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes.
J Virol
; 88(15): 8213-26, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24829346
10.
A tyrosine-to-histidine switch at position 18 of the Ross River virus E2 glycoprotein is a determinant of virus fitness in disparate hosts.
J Virol
; 87(10): 5970-84, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23514884
11.
Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response.
J Virol
; 87(24): 13878-88, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24131709
12.
A replicating RNA vaccine confers protection in a rhesus macaque model of Crimean-Congo hemorrhagic fever.
NPJ Vaccines
; 9(1): 86, 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38769294
13.
Third International Conference on Crimean-Congo Hemorrhagic Fever in Thessaloniki, Greece, September 19-21, 2023.
Antiviral Res
; 225: 105844, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38428749
14.
Single dose, dual antigen RNA vaccines protect against lethal Crimean-Congo haemorrhagic fever virus infection in mice.
EBioMedicine
; 101: 105017, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38382314
15.
Crimean-Congo haemorrhagic fever virus uses LDLR to bind and enter host cells.
Nat Microbiol
; 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38548922
16.
Crimean-Congo haemorrhagic fever virus.
Nat Rev Microbiol
; 21(7): 463-477, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36918725
17.
CD8+ T-cells target the Crimean-Congo haemorrhagic fever virus Gc protein to control the infection in wild-type mice.
EBioMedicine
; 97: 104839, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37866114
18.
Species-specific MARCO-alphavirus interactions dictate chikungunya virus viremia.
Cell Rep
; 42(5): 112418, 2023 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37083332
19.
Favipiravir and Ribavirin protect immunocompetent mice from lethal CCHFV infection.
Antiviral Res
; 218: 105703, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37611878
20.
Replicating RNA vaccination elicits an unexpected immune response that efficiently protects mice against lethal Crimean-Congo hemorrhagic fever virus challenge.
EBioMedicine
; 82: 104188, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35907368